|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 31/337 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| C07C 217/84 | (2006.01) |
| (11) | Number of the document | 3518911 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17857371.3 |
| Date of filing the European patent application | 2017-09-27 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-12-10 |
| (86) | Number | PCT/US2017/053834 |
| Date | 2017-09-27 |
| (87) | Number | WO 2018/064231 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662400495 P | 2016-09-27 | US |
| (72) |
HATTERSLEY, Gary , US
|
| (73) |
Radius Pharmaceuticals, Inc. ,
22 Boston Wharf Road, 7th Floor, Boston, MA 02210,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | RAD1901, skirtas naudoti kiaušidžių vėžio gydymui |
| RAD1901 FOR USE IN TREATING OVARIAN CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 9 | 208.00 EUR |
| 2026-09-27 |